Phosphodiesterase inhibitors in psychiatric disorders

被引：0
|
作者：
Mohammad Amin Sadeghi
Ehsan Nassireslami
Mojtaba Yousefi Zoshk
Yasaman Hosseini
Kourosh Abbasian
Mohsen Chamanara
机构：
[1] AJA University of Medical Sciences,Toxicology Research Center
[2] AJA University of Medical Sciences,Department of Pharmacology, School of Medicine
[3] AJA University of Medical Sciences,Trauma Research Center
[4] AJA University of Medical Sciences,Department of Pediatrics
[5] AJA University of Medical Sciences,Cognitive Neuroscience Center, School of Medicine
[6] AJA University of Medical Sciences,Management and Health Economics Department
来源：
Psychopharmacology | 2023年 / 240卷
关键词：
Phosphodiesterase; Phosphodiesterase inhibitor; Depression; Anxiety; Post-traumatic stress disorder; Schizophrenia; Bipolar disorder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1201 / 1219
页数：18
相关论文
共 50 条
  • [1] Phosphodiesterase inhibitors in psychiatric disorders
    Sadeghi, Mohammad Amin
    Nassireslami, Ehsan
    Zoshk, Mojtaba Yousefi
    Hosseini, Yasaman
    Abbasian, Kourosh
    Chamanara, Mohsen
    PSYCHOPHARMACOLOGY, 2023, 240 (06) : 1201 - 1219
  • [2] Phosphodiesterase 5 inhibitors in vascular systemic disorders
    Allanore, Yannick
    JOINT BONE SPINE, 2012, 79 (04) : 338 - 340
  • [3] Phosphodiesterase 10 inhibitors in clinical development for CNS disorders
    Geerts, Hugo
    Spiros, Athan
    Roberts, Patrick
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (06) : 553 - 560
  • [4] Phosphodiesterase 10 Inhibitors - Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery
    Zagorska, Agnieszka
    Partyka, Anna
    Bucki, Adam
    Gawalska, Alicja
    Czopek, Anna
    Pawlowski, Maciej
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (29) : 3455 - 3481
  • [5] Glycine transport inhibitors for the treatment of psychiatric disorders
    Javitt, D. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S230 - S231
  • [6] Psychiatric disorders associated with immune checkpoint inhibitors
    Zhou, C.
    Lin, A.
    Gu, T.
    Zhang, J.
    Luo, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1131 - S1131
  • [7] Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study
    Jiang, Miaomiao
    Yan, Weiheng
    Zhang, Yuyanan
    Lu, Zhe
    Lu, Tianlan
    Zhang, Dai
    Li, Jun
    Wang, Lifang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [8] Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders
    Kumar, Ashish
    Kim, Fred
    Song, Dong-Keun
    Choung, Jai Jun
    AGING AND DISEASE, 2024, 15 (05): : 2008 - 2014
  • [9] Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study
    Miaomiao Jiang
    Weiheng Yan
    Yuyanan Zhang
    Zhe Lu
    Tianlan Lu
    Dai Zhang
    Jun Li
    Lifang Wang
    Journal of Translational Medicine, 21
  • [10] Natural and Synthetic Phosphodiesterase Inhibitors in 2023: an Update on the Impact on Neurological and Psychiatric Conditions
    Ribaudo, Giovanni
    Gianoncelli, Alessandra
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (06) : 568 - 570
12345